Dr. Bradstreet Lecturing 4 times at Autism One Conference in Chicago Illinois in May 2015

Follow the link below to register.

http://www.autismone.org/content/conference-membership-registration

Dr. Bradstreet’s Schedule for Autism One 2015

THURSDAY

3:00 pm – 5:00 pm

Louvre 3 CME – CM…, Confere… Advances in Understanding the Gut-Immune-Brain Link in Autism — CME program for medical professionals
James Jeffrey Bradstreet, MD
FRIDAY

8:00 am – 9:00 am

Avedon Bio – B…, Confere… How Close Are We To An Autism Cure? Part 1
James Jeffrey Bradstreet, MD
FRIDAY

5:15 pm – 6:30 pm

Cassatt Bio – B…, Confere… Understanding the Power of Magnetic Resonance Therapy — MRT(sm) — from the Parent’s Perspective.
James Jeffrey Bradstreet , MD
Kevin Murphy, MD
SATURDAY

8:00 am – 9:00 am

Cassatt Bio – B…, Confere… How Close Are We To An Autism Cure? Part 2
James Jeffrey Bradstreet, MD

Lecture Highlights:

James Jeffrey Bradstreet, MD, MD(H), FAAFP, FMAPS

Dr. Bradstreet received undergrad and medical degrees from University of South Florida. His residency training was at Wilford Hall USAF Medical Center, with training at Brooks School of Aerospace Medicine and Randolph AFB. He is an adjunct professor and faculty for Autism Collaboration & Education at Western U in CA and a visiting professor at Southwest College of Naturopathic Medicine. He is extensively published on biomedical issues of autism and was PI of two landmark studies: 1) involving a new methodology to view the brain with ultrasound, and 2) a double-blind study of the use of transcranial magnetic stimulation using a method known as MRT, for the treatment of autism — both registered with clinicaltrials.gov. Phase one of the ultrasound study was recently published in Frontiers in Human Neuroscience, and the MRT study completed in June of 2014. He is director of the Brain Treatment Center of Atlanta and is licensed in Georgia, Florida, California and Arizona.

Special Report: During Autism One, Dr. Bradstreet will introduce new observations related to transcranial laser (LLLT) applications for autism, and announce the new collaborative efforts to improve the specificity of medical marijuana therapy for autism related brain syndromes. [Note; Medical Marijuana is only legally available in specific states. The federal regulations on these state rules are in chaos].

Advances in Understanding the Gut-Immune-Brain Link in Autism — CME program for medical professionals

This course will explore the latest research on the microbiota regulation of the endocannabinoid and immune systems. The attendee will become familiar with the components of the endocannabinoid system (ECS) and understand what fatty acids act as natural ligands for the various receptors. They will understand the difference between type 1 and 2 receptors as well as the transient receptor potential vanilloid type 1 ion channel and the unique G-couple receptors and their function. The process whereby dietary fats and carbohydrates act upon by the microbiome to create changes in ECS regulation and the implications for the brain’s intrinsic immune system will be presented. The course describes the critical role of Vitamin D, its receptors and transporter proteins, and their interactions with the ECS. Finally, the novel fatty acid: palmitoylethanolamide (PEA) is an endogenous fatty acid amide, belonging to the class of nuclear factor agonists. Has no binding to CB1 or 2, but attaches to peroxisome proliferator-activated receptor alpha (PPAR-α) and cannabinoid-like G-coupled receptors GPR55 and GPR119. PEA is a powerful regulator of mast cells and in both human and animal studies has anti-inflammatory properties, which have implications for ASD immune and gastrointestinal dysfunction.

How Close Are We To An Autism Cure? Part 1

Dr. Bradstreet has been involved in autism related treatment and clinical research for nearly 2 decades. During that time, the theory of a genetic cause of autism has continued to decline, while the emergence of the “environment-gene” interaction theory of autism has gained in favor among scientists and parents. Clearly, autism is one of the most complex of all human disorders and challenges our understanding of the gut ecosystem, the immune pathways in the gut and the brain, and, ultimately, the regulation of brain physics. As complex as all that is, pathways for healing have emerged and more and more children are experiencing dramatic improvements – some to the extent that everyone would consider them “cured”. This course will present the foundations of healing and serves as the introduction to next presentation.

Understanding the Power of Magnetic Resonance Therapy — MRT(sm) — from the Parent’s Perspective.

Dr. Bradstreet will introduce the science of MRT(sm) and the ongoing research into brain physics and then introduce a panel of parents to further describe a balanced view of what may be expected from this unique form of intervention. In MRT treatment, BTC has augmented the well-established and safe technique of transcranial magnetic stimulation (TMS) through a proprietary algorithm to deliver a patient-specific treatment based on the results of a quantitative electroencephalogram (EEG) and electrocardiography (ECG). In one expert’s words, “What the Brain Treatment Center has done is revolutionary. Using evidence-based principles with TMS, they have created a delivery system that customizes treatment based on the patient’s own QEEG….” [Dr. Kevin T. Murphy]. Dr. Bradstreet will share the one year outcome observations for the study patients.

How Close Are We To An Autism Cure? Part 2

Although toxins from industry, agriculture, and more shape the environment for children with autism, the largest and most impacted environmental factor for autism remains the internal ecosystem living in the intestines. That environment is shaped by complex communities of microbes interacting with the diet and the immune defenses of the child. The combined effect of environmental poisons and microbial chemistry directly influence the immune system in critical ways, while also affecting gene expression. The consequence of this interaction is disruption of the vital regulatory mechanisms of the endocannabinoid system (ECS). The ECS has control over mood, cognition, and immune regulation, and its dysfunction is recognized as the root cause of epilepsy, inflammatory bowel disease, cardiovascular disease, type II diabetes, obesity, and neurodegenerative illnesses like Alzheimer’s. Our new research points to the role of Vitamin D deficiency and changes in its binding protein, the gut ecosystem and dysregulation of the ECS as the primary issues in the majority of autism symptoms. Ultimately, the ECS also regulates brain physics in a way that disconnects neuro-processing. All of these issues must be properly repaired for each child to obtain their optimal functioning.

About Dr Bradstreet
Dr Bradstreet is a graduate of the University of South Florida College of Medicine and received his residency training at Wilford Hall USAF Medical Center. He is a Fellow of the American Academy of Family Physicians. He is an Adjunct Professor at the Southwest College of Naturopathic Medicine in Arizona. He is extensively published in the peer-reviewed literature on subjects of autism, oxidative stress, mitochondrial disorders, virology, hyperbaric oxygen, and toxicology (especially heavy metal chelation). He is trained in the the isolation and use of stem cells.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: